Garth Cumberlidge, PhD

President & CEO

Chairman of Eyevensys SAS and former CEO of Mimetogen Pharmaceuticals. Successful track record of ophthalmology drug development, fund-raising and licensing.

John Clement, Ph.D

Exec. VP Business Development

A seasoned biotech executive, having held senior management positions in both R&D and business development with Ciba-Geigy, QLT and iCo.

Przemyslaw(Mike) Sapieha, Ph.D

Founder & Chief Scientific Officer

Director of the Neurovascular Eye Disease Lab at Maisonneuve-Rosemont Hospital Research Centre and Wolfe Professor of translational vision research, Canada Research Chair in retina...